Genetic landscape of extreme responders with anaplastic oligodendroglioma

BACKGROUND: The NRG Oncology RTOG 9402 trial showed significant survival benefit in patients with 1p/19q co-deleted anaplastic oligodendrogliomas (AO) who received both radiation (RT) and chemotherapy (PCV regimen) versus RT alone. Substantial separation of the survival curves was only seen after 7....

Descripción completa

Detalles Bibliográficos
Autores principales: Holdhoff, Matthias, Cairncross, Gregory J., Kollmeyer, Thomas M., Zhang, Ming, Zhang, Peixin, Mehta, Minesh P., Werner-Wasik, Maria, Souhami, Luis, Bahary, Jean-Paul, Kwok, Young, Hartford, Alan C., Chakravarti, Arnab, Yegnasubramanian, Srinivasan, Vogelstein, Bert, Papadopoulos, Nickolas, Kinzler, Kenneth, Jenkins, Robert B., Bettegowda, Chetan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482595/
https://www.ncbi.nlm.nih.gov/pubmed/28388591
http://dx.doi.org/10.18632/oncotarget.16773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482595/
https://www.ncbi.nlm.nih.gov/pubmed/28388591
http://dx.doi.org/10.18632/oncotarget.16773

Ejemplares similares